ArticleFrontiers in pharmacology2026

PRDX1 promotes clear cell renal cell carcinoma progression by modulating EGFR-dependent AKT pathway activation.

Zhi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.